Source: Annual Congress 2005 - Atypical bacteria, fungal and parasitic infections of the lung
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Mise, Z. Ivancevic, A. Bradaric, S. Kotarac, I. Gudelj, J. Tocilj (Split, Croatia). Legionnaire‘s disease and its consequences. Eur Respir J 2005; 26: Suppl. 49, 2612

Member's Comments

No comment yet.

Related content which might interest you: Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma Source: Eur Respir J 2016; 48: 291-293 Year: 2016 Carers in advanced COPD: impact on the disease and impact of the disease Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Understanding the heterogeneity of the disease Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC) Year: 2015 The consequences of microbiome and pathogen dynamics for chronic lung diseases Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation Year: 2012 Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 Pulmonary function after COVID-19 infection and the impact of disease severity. Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation Year: 2021 Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Neonatal chronic lung disease and its long-term consequences Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=99 Year: 2002 Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation Source: Eur Respir J 2011; 38: 749-751 Year: 2011 Why is ILD a different disease in children? Recognising specific diseases in chILDs Source: International Congress 2014 – Interstitial lung disease (ILD) in children Year: 2014 Role of tobacco exposure in the course of COVID-19 disease and the impact of the disease on smoking behavior Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 Projections of the future burden of COPD in the Netherlands by disease severity using a dynamic population model of disease progression Source: Eur Respir J 2004; 24: Suppl. 48, 700s Year: 2004 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 The impact of ethnicity on disease presentation and control in severe asthma Source: Virtual Congress 2021 – New evidence from longitudinal asthma cohorts and other key studies Year: 2021 Long-term risks of cardiovascular events in patients with chronic kidney disease who survived sepsis Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans Year: 2013 Post-viral effects on the susceptibility of developing chronic lung diseases Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021